Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Climacteric ; 23(1): 75-83, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31257934

RESUMO

Objective: The objective of this study was to evaluate the action of soy isoflavones (ISO) and 17ß-estradiol on collagen I (CollI) and sulfated glycosaminoglycans (GAGs) in the bone matrix of diabetic rats.Methods: Sixty adult female rats (Rattus norvegicus albinus) underwent ovariectomy, and then were randomized into six groups of 10 animals each: GI, sham control ovariectomized animals; GII, sham control diabetic (DM) ovariectomized animals; GIII, control ovariectomized animals receiving propylene glycol vehicle; GIV, control ovariectomized DM animals receiving propylene glycol vehicle; GV, ovariectomized DM animals treated with ISO (150 mg/kg by gavage); and GVI, ovariectomized DM animals treated with estrogen (17ß-estradiol, 10 mg/kg, subcutaneously). 17ß-Estradiol was used as a positive control when compared with ISO. To obtain significant depletion of the estrogen levels and subsequent bone loss, a postsurgical period of 90 days was observed. Treatments occurred during 30 consecutive days. After euthanasia, shafts of the animals' femurs were immersed in liquid nitrogen for molecular biology analysis, and the distal femurs were removed and processed for paraffin embedding.Results: ISO (GV) and 17ß-estradiol (GVI) improved bone formation, increasing GAGs and CollI formation when compared to the control group (GIV) (p < 0.05).Conclusions: ISO and 17ß-estradiol contribute to the decrease of bone loss in diabetic rats.


Assuntos
Osso e Ossos/metabolismo , Estradiol/farmacologia , Estrogênios/farmacologia , Isoflavonas/química , Animais , Colágeno Tipo I/análise , Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 1/metabolismo , Estradiol/metabolismo , Estrogênios/metabolismo , Feminino , Glicosaminoglicanos/análise , Humanos , Isoflavonas/metabolismo , Ovariectomia , Pós-Menopausa , Distribuição Aleatória , Ratos
2.
Gynecol Endocrinol ; 35(7): 586-590, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30784335

RESUMO

Ovarian aging is characterized by declines in follicular reserve and oocyte quality due, in part, to increased oxidative stress and apoptosis. Soy isoflavones (ISOs) have been shown to improve ovarian lifespan by acting as antioxidant and antiapoptotic agents. We aimed at evaluating whether ISOs could modulate oxidative stress and reduce apoptosis and improve ovarian follicle survival in middle-aged female rats. Twelve ovary-intact female Wistar rats (12-month-old) were divided into groups: control (CTRL) and ISO, daily treated by gavage with vehicle or soy-ISO extract (150 mg/kg b.w), respectively. After 8 weeks, rats were euthanized and their ovaries removed for histomorphometric (% follicles) and apoptosis (cleaved-caspase-3/BCL2 immunostaining) evaluations, or subjected to biochemical assays to survey reactive oxygen species (ROS) and lipid peroxidation levels and total antioxidant capacity (TAC). The frequency of atretic follicles and number of cleaved-caspase-3-positive cells, as well as the ROS and lipid peroxidation levels, were significantly lower in ISO group compared to CTRL. A significantly higher number of BCL2-positive cells and TAC levels were also observed in ISO group. In conclusion, soy ISOs could decrease follicular atresia, apoptosis and oxidative stress, as well as increase the TAC in ovaries of female rats.


Assuntos
Apoptose/efeitos dos fármacos , Isoflavonas/administração & dosagem , Ovário/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Substâncias Protetoras/administração & dosagem , Animais , Caspase 3/metabolismo , Feminino , Ovário/metabolismo , Ratos , Ratos Wistar , Espécies Reativas de Oxigênio/metabolismo
3.
Climacteric ; 21(1): 75-81, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29231060

RESUMO

AIM: To evaluate the combined effects of streptozotocin-induced diabetes (Di) and ovariectomy in the articular cartilage of rats. METHODS: Forty adult female Wistar rats were ovariectomized (OVX) or sham-operated. After recovery from surgery, the animals were assigned randomly into four groups: OVX control (OVX-C); OVX treated with 10 µg/kg/day of 17ß-estradiol (OVX-E); sham-operated subjected to Di (Sham-Di); and OVX subjected to Di (OVX-Di). After 60 days of treatment, the animals were euthanized and the distal femurs with articular cartilage were processed for paraffin-embedding. Sections were stained with hematoxylin and eosin for histomorphometry, Picro-Sirius Red for collagen, or Alcian Blue for glycosaminoglycan (GAG) content. To detect apoptosis, sections were stained with an antibody to cleaved caspase-3 (casp-3). RESULTS: Articular cartilage thickness and GAG content were significantly lower (p < 0.05) in the OVX-Di group, which also showed a higher number of casp-3-positive chondrocytes than the other groups. Interestingly, the higher percentage (p < 0.05) of mature collagen fibers was seen in the OVX-Di group, may be as a result of a reduced extracellular matrix remodeling of the articular cartilage. CONCLUSION: Our results indicate that the combination of ovariectomy and streptozotocin-induced diabetes produces more deleterious effects in articular cartilage of rats than either condition alone.


Assuntos
Cartilagem Articular/patologia , Diabetes Mellitus Experimental/complicações , Ovariectomia/efeitos adversos , Animais , Densidade Óssea/efeitos dos fármacos , Diabetes Mellitus Experimental/patologia , Estradiol/farmacologia , Feminino , Fêmur/efeitos dos fármacos , Glicosaminoglicanos/análise , Distribuição Aleatória , Ratos , Ratos Wistar , Estreptozocina
8.
Clin Exp Obstet Gynecol ; 40(3): 345-9, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24283162

RESUMO

PURPOSE: To evaluate the morphological aspects in rats subjected to an association of the antiretroviral drugs zidovudine/lopinavir/ritonavir in different doses administered throughout the gestational period. MATERIALS AND METHODS: Forty pregnant rats were randomly allocated into four groups: control (Ctrl) and experimental (Exp1, Exp2, and Exp3), which received zidovudine/lopinavir/ritonavir in the doses of 10/13.3/3.3, 30/39.9/9.9, and 90/119.7/29.7 mg/kg per day from the first to the 20th day of pregnancy, respectively. At term, the animals were euthanized and maternal and fetal organ samples were removed for morphological analysis. RESULTS: No major changes were identified in the group treated with the lowest dosing compared with the control. In group Exp2, the authors found hepatocytes with eosinophilic cytoplasm, pyknotic nuclei, and vasodilation. The proximal convoluted tubules of maternal kidneys showed eosinophilic areas and hyperchromatic nuclei, as well as signs of vasodilation. In the group treated with the highest dose (Exp3); the morphological changes in the maternal kidneys and livers were similar and more pronounced than those found in Exp2. The maternal pancreas of groups Exp2 and Exp3 evidenced moderate and progressive signs of tissue damage. The morphological features of all fetal livers, kidneys, and pancreases were normal. CONCLUSION: High doses of zidovudine/lopinavir/ritonavir association during the entire rat pregnancy period can cause definite morphological changes in maternal liver, kidneys, and pancreas. On the other hand, the corresponding fetal organs were not affected.


Assuntos
Feto/efeitos dos fármacos , Infecções por HIV/tratamento farmacológico , Inibidores da Protease de HIV/administração & dosagem , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Lopinavir/administração & dosagem , Pâncreas/efeitos dos fármacos , Complicações Infecciosas na Gravidez/tratamento farmacológico , Ritonavir/administração & dosagem , Zidovudina/administração & dosagem , Animais , Nitrogênio da Ureia Sanguínea , Creatinina/sangue , Relação Dose-Resposta a Droga , Feminino , Inibidores da Protease de HIV/farmacocinética , Gravidez , Ratos , Ratos Wistar
9.
Clin Exp Obstet Gynecol ; 40(1): 151-4, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23724532

RESUMO

PURPOSE: To evaluate the effects of the association of lopinavir and ritonavir administered during the whole period of rat pregnancy. METHODS: 62 Wistar rats of the EPM-1 variant weighing about 200 g were randomly divided into five groups: two controls (Ctrl = stress control, n = 10; and Ctr2 = drug vehicle control, n = 10) and three experimental ones which were treated with an oral solution of lopinavir/ritonavir (Exp1 = 12.8/3.2 mg/kg b.w., n = 14; Exp2 = 38.4/9.6 mg/kg b.w., n = 14; Exp3 = 115.2/28.8 mg/kg b.w., n = 14) from 'day 0' up to the 20th day of pregnancy. Maternal body weight was recorded at the start of the experiment and on the 7th, 14th and 20th day thereafter. At term (20th day), upon laparotomy and hysterotomy, the rats were anesthetized and the amount of implantations, reabsorptions, living fetuses, placentae and intrauterine deaths were recorded. The collected fetuses and placentae were weighed and the concepts were examined under a stereoscope microscope for external malformations. RESULTS: An apparent dose-unrelated lethal effect of the antiviral association on the pregnant rats was observed; notwithstanding, the body weight gain of the surviving rats had no changes, independent of the considered group. It was noted that the quantitative and qualitative intrauterine content of living term rats was indistinguishable from that of the controls. CONCLUSION: There was some degree of deleterious effects of the administration of the lopinavir/ritonavir association on pregnant rats; such effects eventually led to maternal death. However, neither the surviving rats showed toxicity nor did their concepts present any detectable change which could be related to the drug association.


Assuntos
Fármacos Anti-HIV/toxicidade , Lopinavir/toxicidade , Prenhez/efeitos dos fármacos , Ritonavir/toxicidade , Animais , Feminino , Morte Materna , Gravidez , Ratos , Ratos Wistar
10.
Climacteric ; 16(1): 161-8, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22762389

RESUMO

OBJECTIVE: To evaluate whether soybean extracts and estrogens present additive effects on adult rat uterus. METHODS: Fifty ovariectomized rats were randomly divided into five equal groups of ten animals: Control, treated with vehicle; SE46 and SE120, treated with 46 and 120 mg/kg soybean concentrated extract (SE), respectively; EE, treated with conjugated equine estrogens (CE) 50 µg/kg; SE120 + EE, treated with 50 µg/kg (CE) plus 120 mg/kg SE. The substances were administered daily by gavage for 21 consecutive days. Thereafter the animals were weighed and killed by decapitation; trunk blood was collected for hormone determinations. Uteri were removed immediately and fixed in 10% formaldehyde, followed by dehydration, embedding in paraffin and 6-m sections staining with hematoxylin and eosin for histomorphometric analyses of myometrium and endometrium. After ANOVA analysis of the data, the study was complemented with the Tukey-Kramer test for multiple comparisons. RESULTS: The concentrated extract of soybean at high concentration (SE 120 kg/mg) and estrogens proved to have a trophic effect on the uterus (endometrium and myometrium) of castrated rats. In groups SE120, EE and SE120 + EE, all morphometric parameters examined (number of glands, eosinophils, blood vessels and the glandular area) were increased. No significant addictive effects of soybean extract plus estrogens were detected in the SE120 + EE group. CONCLUSIONS: Our results indicate that soy extract has a trophic effect on rat uterine structures. Treatment of ovariectomized rats with a concentrated soy extract in combination with conjugated estrogens had no addictive effect on the uterine response.


Assuntos
Estrogênios Conjugados (USP)/farmacologia , Estrogênios/farmacologia , Fitoestrógenos/farmacologia , Extratos Vegetais/farmacologia , Útero/anatomia & histologia , Útero/efeitos dos fármacos , Análise de Variância , Animais , Endométrio/anatomia & histologia , Endométrio/efeitos dos fármacos , Estradiol/sangue , Feminino , Genisteína/farmacologia , Isoflavonas/farmacologia , Miométrio/anatomia & histologia , Miométrio/efeitos dos fármacos , Tamanho do Órgão , Ovariectomia , Progesterona/sangue , Ratos , Glycine max
11.
Arq. bras. med. vet. zootec ; Arq. bras. med. vet. zootec. (Online);64(6): 1547-1554, Dec. 2012. ilus
Artigo em Português | LILACS | ID: lil-660223

RESUMO

Foi realizada falha segmentar de 6mm na região metafisária medial da tíbia de 12 coelhos, seguida de preenchimento desta por matriz óssea mineralizada heteróloga fragmentada conservada em glicerina (98%) e metilmetacrilato autoclavado, bem como avaliação por meio da tomografia computadorizada de feixe cônico (cone beam) aos 30, 60 e 90 dias. Houve incorporação gradativa do implante no leito receptor em relação ao tempo em 100% dos casos, o que mostra ser este biologicamente compatível, ao promover reparação da falha óssea, sem sinais de infecção, migração e/ou rejeição, caracterizando-se, assim, como nova opção de substituto ósseo para preenchimento de falhas ósseas.


A 6mm segmental defect was performed on the metaphyseal region of the tibia of 12 rabbits and the autoclaved fragmented heterolog cortical bone conserved in glycerin (98%) and methylmethacrylate was used as a bone graft for the reconstruction. The graft was placed in the receptor bed and its integration was evaluated by computed tomography after 30, 60 and 90 days. There was gradual bone graft incorporation in the receptor bed during the time in 100% of the cases. Fragmented cortical bone heterograft and methylmethacrylate was biologically compatible and promotes bone defect reparation without signs of infection, migration and or rejection, featuring a new option of osseous substitute to fill in bone defects.


Assuntos
Animais , Coelhos , Matriz Óssea , Metilmetacrilato , Tíbia/anormalidades , Tomografia Computadorizada de Feixe Cônico/veterinária , Osso e Ossos/anormalidades , Tomografia Computadorizada por Raios X
12.
Clin Exp Obstet Gynecol ; 39(2): 205-8, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22905465

RESUMO

PURPOSE: To evaluate the effects at term of a highly active antiretroviral drug association when administered for the whole period of rat pregnancy. METHODS: Forty pregnant rats weighing about 200 g were randomly divided into four groups: a control group (Ctr = drug vehicle control, n=10) and three experimental groups, which were treated with an oral solution of zidovudine-stavudine (Explx = 10/1 mg/kg b.w., n=10; Exp3x = 30/3 mg/kg b.w., n=10; Exp9x = 90/9 mg/kg b.w., n=10) from "day 0" up to the 20th day of pregnancy. Maternal body weights were recorded at the start of the experiment and on the 7th, 14th and 20th day thereafter. At term (20th day) the rats were anesthetized and submitted to hysterotomy. Implantations, reabsorptions, living fetuses, placentae and intrauterine deaths were looked for and recorded. The collected fetuses and placentae were weighed and the concepts were examined by a stereoscopic microscope looking for external malformations. RESULTS: No significant alterations due to the antiretroviral drug treatment could be detected regarding the number of implantations, fetuses, placentae, absorptions and malformations nor regarding maternal and fetal mortality. CONCLUSIONS: Administration of the association zidovudine/stavudine for the whole period of rat pregnancy did not interfere with the maternal, fetal and placental weight gain as well as abnormalities detectable by the employed methodology.


Assuntos
Fármacos Anti-HIV/farmacologia , Resultado da Gravidez , Estavudina/farmacologia , Zidovudina/farmacologia , Animais , Bioensaio , Modelos Animais de Doenças , Combinação de Medicamentos , Feminino , Infecções por HIV/tratamento farmacológico , Gravidez , Complicações Infecciosas na Gravidez/tratamento farmacológico , Ratos , Estavudina/administração & dosagem , Aumento de Peso/efeitos dos fármacos , Zidovudina/administração & dosagem
13.
Arq. bras. med. vet. zootec ; 64(6): 1547-1554, 2012. ilus
Artigo em Português | VETINDEX | ID: vti-10899

RESUMO

Foi realizada falha segmentar de 6mm na região metafisária medial da tíbia de 12 coelhos, seguida de preenchimento desta por matriz óssea mineralizada heteróloga fragmentada conservada em glicerina (98%) e metilmetacrilato autoclavado, bem como avaliação por meio da tomografia computadorizada de feixe cônico (cone beam) aos 30, 60 e 90 dias. Houve incorporação gradativa do implante no leito receptor em relação ao tempo em 100% dos casos, o que mostra ser este biologicamente compatível, ao promover reparação da falha óssea, sem sinais de infecção, migração e/ou rejeição, caracterizando-se, assim, como nova opção de substituto ósseo para preenchimento de falhas ósseas.(AU)


A 6mm segmental defect was performed on the metaphyseal region of the tibia of 12 rabbits and the autoclaved fragmented heterolog cortical bone conserved in glycerin (98%) and methylmethacrylate was used as a bone graft for the reconstruction. The graft was placed in the receptor bed and its integration was evaluated by computed tomography after 30, 60 and 90 days. There was gradual bone graft incorporation in the receptor bed during the time in 100% of the cases. Fragmented cortical bone heterograft and methylmethacrylate was biologically compatible and promotes bone defect reparation without signs of infection, migration and or rejection, featuring a new option of osseous substitute to fill in bone defects.(AU)


Assuntos
Animais , Coelhos , Matriz Óssea , Metilmetacrilato , Tíbia/anormalidades , Tomografia Computadorizada de Feixe Cônico/veterinária , Tomografia Computadorizada por Raios X , Osso e Ossos/anormalidades
14.
Clin Exp Obstet Gynecol ; 38(2): 126-30, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21793271

RESUMO

PURPOSE: To evaluate biochemical and morphological effects on rats submitted to three different doses of the association zidovudine and ritonavir administered throughout pregnancy. METHODS: Forty pregnant EPM-1 Wistar rats weighing about 200 g were randomly divided into the control group (Ctr = drug vehicle control, n = 10) and three experimental ones which were treated with an oral solution of zidovudine/ritonavir (Exp1 = 10/20 mg/kg bw, n = 10; Exp2 = 30/60 mg/kg bw, n = 10; Exp3 = 90/180 mg/kg bw, n = 10) from 'day 0' up to the 20th day of pregnancy. At term (20th day) the rats were anesthetized. Blood and fetal and maternal organ samples (livers and kidneys) were taken for morphological and biochemical analyses. RESULTS: Upon histological examinations fetal livers and kidneys appeared normal. In contrast the maternal samples revealed structural alterations. Maternal kidneys of the three experimental groups exhibited progressive and dose-dependent histological alterations; liver alterations were detected only in Exp3. Blood levels of AST and ALT were not significantly different from the control group but urea and creatinine levels were lower in groups Exp3 and Exp1. CONCLUSIONS: The administration of zidovudine plus ritonavir throughout rat pregnancy can cause morphological as well as functional changes in maternal kidneys.


Assuntos
Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Fármacos Anti-HIV/farmacologia , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Complicações Infecciosas na Gravidez/tratamento farmacológico , Ritonavir/farmacologia , Zidovudina/farmacologia , Síndrome da Imunodeficiência Adquirida/patologia , Análise de Variância , Animais , Fármacos Anti-HIV/uso terapêutico , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Feminino , Rim/patologia , Fígado/patologia , Gravidez , Ratos , Ratos Wistar , Ritonavir/uso terapêutico , Zidovudina/uso terapêutico
15.
Clin Exp Obstet Gynecol ; 38(1): 28-32, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21485721

RESUMO

PURPOSE: To evaluate at term the effects of a highly active antiretroviral (HAAR) drug association administered during the entire period of rat pregnancy. METHODS: Three groups (n = 10 each) of adult pregnant rats were treated with an oral solution of HAAR (Exp 1 = 10/5/20 mg/kg b.w.; Exp 2 = 30/15/60 mg/kg b.w.; Exp 3 = 90/45/180 mg/kg b.w.) from day "0" up to the 20th day of pregnancy. A fourth group served as a control. At term (20th day) the rats were killed under deep anesthesia and the number of implantations, resorptions, living fetuses, placentae and intrauterine deaths were recorded. RESULTS: The highest HAAR doses caused lower maternal weight gain, lower litter weights, and lower placental weights compared to the control group. CONCLUSIONS: HAAR during the entire period of rat pregnancy can reduce maternal body weight gain and lower term placental weight.


Assuntos
Fármacos Anti-HIV/farmacologia , Terapia Antirretroviral de Alta Atividade/métodos , Prenhez/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Peso Corporal/efeitos dos fármacos , Feminino , Lamivudina/farmacologia , Tamanho da Ninhada de Vivíparos/efeitos dos fármacos , Gravidez , Distribuição Aleatória , Ratos , Ratos Wistar , Ritonavir/farmacologia , Estatísticas não Paramétricas , Zidovudina/farmacologia
16.
Transplant Proc ; 42(2): 448-50, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20304161

RESUMO

To study whether treatment with L-arginine (ARG), a substrate of nitric oxide biosynthesis, attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rabbits treated with ARG (100 mgxkg(-1), intravenously) or saline solution (SS) prior to I (60 minutes) by occlusion of superior mesenteric artery and/or during R (120 minutes). After I or I/R, 2-cm jejunal segments were isolated and mounted in an organ bath to study of neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained (hematoxylin and eosin) for analysis by optical microscopy. Compared to the sham group, jejunal contractions were similar in I + ARG, but reduced in I + SS, I/R + SS, and I/R + ARG groups. The jejunal enteric nerves were damaged in I + SS, I/R + SS, and I/R + ARG, but not in I + ARG group, suggesting that ARG can attenuate intestinal dysfunctions due to I, but not to R.


Assuntos
Arginina/farmacologia , Intestinos/irrigação sanguínea , Óxido Nítrico/biossíntese , Traumatismo por Reperfusão/prevenção & controle , Animais , Arginina/uso terapêutico , Circulação Sanguínea , Veia Femoral/fisiologia , Motilidade Gastrointestinal/efeitos dos fármacos , Motilidade Gastrointestinal/fisiologia , Isquemia/fisiopatologia , Jejuno/irrigação sanguínea , Jejuno/efeitos dos fármacos , Jejuno/patologia , Artéria Mesentérica Superior/fisiologia , Coelhos , Reperfusão/efeitos adversos , Traumatismo por Reperfusão/fisiopatologia
17.
Transplant Proc ; 42(2): 451-3, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20304162

RESUMO

To study whether treatment with the beta-blocker atenolol (AT) attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rabbits were treated with AT (1 mg.kg(-1), introvenously) or saline solution (SS) prior to I (60 minutes), which was produced by occlusion of the superior mesenteric artery, and/or R (120 minutes). After I or I/R, 2-cm jejunal segments were mounted in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained hematoxylin and eosin for analysis by optical microscopy. Compared to the sham group, the jejunal contractions were similar in the I + AT and the I/R + AT groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS groups, but not in the I + AT and the I/R + AT. These results suggest that AT may attenuate intestinal dysfunction caused by I and I/R.


Assuntos
Atenolol/uso terapêutico , Enteropatias/tratamento farmacológico , Intestinos/irrigação sanguínea , Jejuno/fisiologia , Traumatismo por Reperfusão/tratamento farmacológico , Animais , Circulação Sanguínea , Estimulação Elétrica , Enteropatias/etiologia , Jejuno/irrigação sanguínea , Jejuno/efeitos dos fármacos , Masculino , Artéria Mesentérica Superior/fisiologia , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Cloreto de Potássio/farmacologia , Coelhos
18.
Transplant Proc ; 42(2): 454-6, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20304163

RESUMO

To study if the treatment with adenosine (ADO), an agonist of adenosine receptors, attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), we treated rabbits with ADO (15 mg x kg(-1), intravenously) or saline solution (SS) to I (60 minutes) before occlusion of superior mesenteric artery and/or R (120 min). After I or I/R, isolated jejunal segments (2 cm) were mounted in an organ bath to study nerve-mediated contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained (hematoxylin and eosin) for analysis by optical microscopy. Compared to the sham group, the jejunal contractions were similar in I + ADO, but reduced in I + SS, I/R + SS, and I/R + ADO groups. We concluded that the jejunal enteric nerves were damaged in I + SS, I/R + SS, and I/R + ADO, but not in I + ADO group. These results suggested that ADO attenuated intestinal dysfunction due to I, but not to R.


Assuntos
Adenosina/farmacologia , Intestinos/irrigação sanguínea , Traumatismo por Reperfusão/tratamento farmacológico , Animais , Circulação Sanguínea , Estimulação Elétrica , Veia Femoral/efeitos dos fármacos , Veia Femoral/fisiologia , Jejuno/irrigação sanguínea , Jejuno/efeitos dos fármacos , Jejuno/fisiologia , Masculino , Artéria Mesentérica Superior/fisiologia , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Cloreto de Potássio/farmacologia , Agonistas do Receptor Purinérgico P1 , Coelhos , Cloreto de Sódio/farmacologia
19.
Transplant Proc ; 42(2): 457-60, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20304164

RESUMO

To study whether treatment with L-nitro-arginine methyl ester (L-NAME), an inhibitor of nitric oxide biosynthesis, attenuates intestinal dysfunction caused by ischemia (I) and/or reperfusion (R), rabbits were treated with L-NAME (15 mgxkg(-1), intervenously) or saline olution (SS) prior to I (60 minutes) induced by occlusion of superior mesenteric artery and/or R (120 minutes). After I or I/R, isolated jejunal segments (2 cm) were mounted in an organ bath to study nerve-mediated contractions stimulated by electrical pulses or KCI using a digital recording system. Thin jejunal slices were stained (hematoxylin and eosin) for analysis by optical microscopy. Compared with a sham group, the jejunal contractions were similar in the I/R + L-NAME, but reduced in I + SS, I/R + SS, and I + L-NAME groups. The jejunal enteric nerves were damaged in the I + SS, I/R + SS, and I + L-NAME cohorts, but not among the I/R + L-NAME cohort. These results suggested that L-NAME attenuated intestinal dysfunction caused by R but not by I.


Assuntos
Motilidade Gastrointestinal/efeitos dos fármacos , Enteropatias/prevenção & controle , NG-Nitroarginina Metil Éster/farmacologia , Traumatismo por Reperfusão/prevenção & controle , Traumatismo por Reperfusão/fisiopatologia , Animais , Estimulação Elétrica , Isquemia/fisiopatologia , Jejuno/efeitos dos fármacos , Jejuno/inervação , Jejuno/fisiologia , Masculino , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Coelhos , Cloreto de Sódio/farmacologia
20.
Transplant Proc ; 42(2): 461-4, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20304165

RESUMO

To study whether treatment with 5'-adenosine triphosphate (ATP), an agonist of P2 purine receptors, attenuated intestinal dysfunction caused by ischemia (I) and/or reperfusion (R), rabbits were treated with ATP (15 mgxkg(-1), intravenously) or saline solution (SS) 60 minutes before I by occlusion of the superior mesenteric artery and/or R (120 minutes). After I or I/R isolated 2-cm jejunal segments were mounted in an organ bath to study nerve-mediated contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained (hematoxylin and eosin) for optical microscopy. Compared to a sham group, the jejunal contractions were similar to sham hosts among I + ATP, but reduced in I + SS, I/R + SS, and I/R + ATP groups. The jejunal-enteric nerves were damaged in I + SS, I/R + SS, and I/R + ATP, but not the I + ATP group. These results suggested that ATP attenuated intestinal dysfunction produced by I, but not that caused by R.


Assuntos
Trifosfato de Adenosina/farmacologia , Intestinos/irrigação sanguínea , Isquemia/fisiopatologia , Jejuno/irrigação sanguínea , Traumatismo por Reperfusão/fisiopatologia , Animais , Circulação Sanguínea/efeitos dos fármacos , Circulação Sanguínea/fisiologia , Isquemia/tratamento farmacológico , Jejuno/efeitos dos fármacos , Jejuno/inervação , Masculino , Artéria Mesentérica Superior/efeitos dos fármacos , Artéria Mesentérica Superior/fisiopatologia , Coelhos , Cloreto de Sódio/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA